J Neurosurg Spine 42:705–717, 2025
This systematic review and meta-analysis evaluates the outcomes of cervical disc arthroplasty (CDA) versus anterior cervical discectomy and fusion (ACDF) in treating cervical spondylotic myelopathy (CSM). Based on 12 randomized controlled trials including 2,612 patients, the study found that CDA shows superior clinical effectiveness and a more favorable safety profile than ACDF. Neck pain improvement (VAS) with CDA was clinically meaningful within the first postoperative year. CDA also had lower reoperation rates and reduced incidence of adjacent segment disease (ASD), although with slightly longer operative times. Further high-quality, large-scale trials are needed to confirm these findings.
Key Points
• • Objective: Compare the efficacy and safety of CDA vs. ACDF in CSM patients through meta-analysis.
• • Methods: 12 RCTs with 2,612 patients (1,464 CDA, 1,148 ACDF); outcomes included NDI, VAS, ROM, SF-36, complications, and reoperations.
• • Overall success: Higher in CDA group (RR 1.21; p = 0.004).
• • Neck pain (VAS): Significantly improved in CDA up to 12 months post-op; clinically meaningful.
• • Arm pain (VAS): Slight improvement at 3 and 12 months; not clinically significant.
• • NDI scores: Statistically better in CDA, though often below MCID thresholds.
• • ROM: Better preserved in CDA; data limited and heterogeneous.
• • Quality of life (SF-36): No significant differences between groups.
• • Operative time: Longer in CDA (MD 18.75 min; p < 0.00001).
• • Complications: Similar blood loss and adverse event rates; lower ASD and reoperation rates in CDA.
• • Limitations: Limited CSM-specific data, inconsistent surgical protocols, and risk of bias in several trials.
• • Conclusion: CDA offers better early clinical outcomes and fewer mechanical complications than ACDF, but broader validation is needed.
You must be logged in to post a comment.